NYSEAMERICAN:INTT - inTEST Stock Price, News, & Analysis

+0.01 (+0.21 %)
(As of 06/19/2019 05:30 AM ET)
Today's Range
Now: $4.81
50-Day Range N/A
52-Week Range
Now: $4.81
Volume40,800 shs
Average Volume36,025 shs
Market Capitalization$50.82 million
P/E RatioN/A
Dividend YieldN/A
inTEST Corporation designs, manufactures, and markets thermal management products and semiconductor automated test equipment interface solutions worldwide. The company operates in two segments, Thermal Products (Thermal) and Electromechanical Semiconductor Products (EMS). The Thermal segment offers ThermoStream temperature management tools, MobileTemp systems, ThermoChambers, Thermal Platforms, ThermoChuck precision vacuum platform assemblies, Thermonics temperature conditioning products, and EKOHEAT and EASYHEAT induction heating systems. Read More…

Industry, Sector and Symbol

Industry Semiconductors
SectorComputer and Technology
Previous SymbolNYSEMKT:INTT



Sales & Book Value

Annual SalesN/A



Market Cap$50.82 million
Next Earnings Date8/1/2019 (Estimated)
OptionableNot Optionable

Receive INTT News and Ratings via Email

Sign-up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter.

inTEST (NYSEAMERICAN:INTT) Frequently Asked Questions

What is inTEST's stock symbol?

inTEST trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INTT."

How were inTEST's earnings last quarter?

inTEST Co. (NYSEAMERICAN:INTT) announced its earnings results on Thursday, May, 9th. The semiconductor company reported $0.14 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.15 by $0.01. The semiconductor company earned $18.06 million during the quarter. View inTEST's Earnings History.

When is inTEST's next earnings date?

inTEST is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for inTEST.

What price target have analysts set for INTT?

2 equities research analysts have issued 1 year price objectives for inTEST's stock. Their forecasts range from $9.00 to $9.00. On average, they anticipate inTEST's stock price to reach $9.00 in the next year. This suggests a possible upside of 87.1% from the stock's current price. View Analyst Price Targets for inTEST.

What is the consensus analysts' recommendation for inTEST?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for inTEST in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for inTEST.

Has inTEST been receiving favorable news coverage?

Headlines about INTT stock have been trending very negative this week, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. inTEST earned a media sentiment score of -3.1 on InfoTrie's scale. They also assigned media coverage about the semiconductor company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for inTEST.

Are investors shorting inTEST?

inTEST saw a increase in short interest during the month of May. As of May 15th, there was short interest totalling 17,500 shares, an increase of 18.2% from the April 15th total of 14,800 shares. Based on an average trading volume of 35,200 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.2% of the company's shares are sold short. View inTEST's Current Options Chain.

Who are some of inTEST's key competitors?

What other stocks do shareholders of inTEST own?

Based on aggregate information from My MarketBeat watchlists, some companies that other inTEST investors own include Baozun (BZUN), Applied Materials (AMAT), NVIDIA (NVDA), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Nektar Therapeutics (NKTR), Celgene (CELG), Lam Research (LRCX), Micron Technology (MU) and Bank of America (BAC).

Who are inTEST's key executives?

inTEST's management team includes the folowing people:
  • Mr. James Pelrin, Pres, CEO & Director (Age 67)
  • Mr. Hugh T. Regan Jr., Treasurer, CFO & Sec. (Age 59)

Who are inTEST's major shareholders?

inTEST's stock is owned by a number of of institutional and retail investors. Top institutional investors include AJO LP (2.45%), Cadence Capital Management LLC (2.26%), LSV Asset Management (1.90%), Wedge Capital Management L L P NC (1.73%), Acadian Asset Management LLC (0.77%) and Bailard Inc. (0.52%). Company insiders that own inTEST stock include Kristen Holt Thompson, Nokomis Capital, LLC, Robert E Matthiessen, Thomas A Satterfield Jr and William Kraut. View Institutional Ownership Trends for inTEST.

Which major investors are selling inTEST stock?

INTT stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Bailard Inc. and Spark Investment Management LLC. Company insiders that have sold inTEST company stock in the last year include Robert E Matthiessen and William Kraut. View Insider Buying and Selling for inTEST.

Which major investors are buying inTEST stock?

INTT stock was bought by a variety of institutional investors in the last quarter, including LSV Asset Management, Wedge Capital Management L L P NC, O Shaughnessy Asset Management LLC, Alambic Investment Management L.P., Globeflex Capital L P, Acadian Asset Management LLC and Cadence Capital Management LLC. View Insider Buying and Selling for inTEST.

How do I buy shares of inTEST?

Shares of INTT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is inTEST's stock price today?

One share of INTT stock can currently be purchased for approximately $4.81.

How big of a company is inTEST?

inTEST has a market capitalization of $50.82 million. inTEST employs 209 workers across the globe.View Additional Information About inTEST.

What is inTEST's official website?

The official website for inTEST is http://www.intest.com/.

How can I contact inTEST?

inTEST's mailing address is 804 E Gate Dr Ste 200, MOUNT LAUREL, NJ 08054-1209, United States. The semiconductor company can be reached via phone at +1-856-5058800.

MarketBeat Community Rating for inTEST (NYSEAMERICAN INTT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  109 (Thanks for Voting!)
Underperform Votes:  120 (Thanks for Voting!)
Total Votes:  229
MarketBeat's community ratings are surveys of what our community members think about inTEST and other stocks. Vote "Outperform" if you believe INTT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INTT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel